Add like
Add dislike
Add to saved papers

Long-term results of omental transplantation for chronic occlusive arterial diseases.

Twenty cases of thromboangitis obliterans (21 limbs) and five cases of atherosclerosis obliterans (five limbs) were treated with omental transplantation. Angiographic findings in these patients showed poor distal run-off, and direct reconstructive surgery was not indicated. Follow-up studies were conducted for an average of five years and one month (3 mos to 9 yrs. and 8 mos.). The long-term follow-up of 19 cases with thromboangitis obliterans (TAO) (20 limbs) revealed excellent results in 62%, good results in 19% and poor results in 19%. The results of the five cases with atherosclerosis obliterans (ASO) (5 limbs) were good in 20% and poor in 80%. Long-term results of omental transplantation show it to be remarkably effective in treating TAO but not ASO.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app